Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced that the company has joined the US AI Safety Institute Consortium (AISIC), a group established by the Department of Commerce’s National Institute of Standards and Technology (NIST) to support the development and deployment of trustworthy and safe artificial intelligence.
Oxford Nanopore Technologies Collaborates With Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Twist Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bio Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Twist Bio and Element Bio Collaborate on Exome Sequencing Solutions
Twist Bio Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications